Clinical Trial Update: A Prospective Study to Evaluate the Addition of Subcutaneous Recombinant Human-Luteinizing Hormone With Recombinant Human-Follicle Stimulating Hormone on Follicular Development in Women Undergoing Ovarian Stimulation for Assisted Reproductive Technologies [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether adding subcutaneous recombinant human LH to recombinant FSH improves follicular development during ovarian stimulation for as…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Gonal-F (follitropin alfa)
• Luveris (lutropin alfa)

Snippet

Sponsor: EMD Serono | Conditions: Infertility, Ovarian Stimulation | Phase 3 | Status: COMPLETED | Results posted: 2011-03-18